FGFR1 Cooperates With EGFR in Lung Cancer Oncogenesis, and Their Combined Inhibition Shows Improved Efficacy

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.12.021
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

P1.13-21 Clinical Efficacy and Safety of Apatinib Combined With EGFR - TKIs in Advanced Non-Small Cell Lung Cancer With EGFR - TKIs Resistance

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Combined Therapy With EGFR TKI and Gambogic Acid for Overcoming Resistance in EGFR‑T790M Mutant Lung Cancer

Oncology Letters
Cancer ResearchOncology
2015English

Selective Inhibition of BCL2 Shows Antitumor Effects in Lung Cancer

Cancer Discovery
Oncology
2015English

Dual Inhibition of EGFR and mTOR Pathways in Small Cell Lung Cancer

British Journal of Cancer
Cancer ResearchOncology
2010English

Dual Inhibition of EGFR With Afatinib and Cetuximab in Kinase Inhibitor-Resistant EGFR-Mutant Lung Cancer With and Without T790M Mutations

Cancer Discovery
Oncology
2014English

MYCxing It Up With FGFR1 in Squamous Cell Lung Cancer

Cancer Discovery
Oncology
2014English

Efficacy of Combined VEGFR1-3, PDGFα/β, and FGFR1-3 Blockade Using Nintedanib for Esophagogastric Cancer

Clinical Cancer Research
Cancer ResearchOncology
2019English

Glucosylated Epigallocatechin Gallate (EGCG) Derivatives Combined With EGFR Tyrosine Kinase Inhibitor Overcome Resistance in EGFR T790M Mutant Lung Cancer

Biomedical Journal of Scientific & Technical Research
2019English

EGFR Cooperates With EGFRvIII to Recruit Macrophages in Glioblastoma

Cancer Research
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy